A patient with suspected acral melanoma requested surveillance rather than the recommended urgent excision biopsy. This raises a conflict between respect for patient autonomy and the need for timely investigation of a potentially serious malignancy. We explore how clinicians should respond when a capacitous patient declines the recommended cancer pathway.